A federal court in New Jersey has granted summary judgment of non-infringement of one patent in generic maker Barr Pharmaceuticals Inc.'s patent challenge against Sanofi-Aventis’ Allegra allergy drug, Barr said.
Indian drug maker Ranbaxy Laboratories Ltd. and Israeli partner Teva Pharmaceuticals have vowed to file an immediate appeal of a New Jersey federal court’s preliminary injunction against sales of a generic version of Pfizer’s hypertension drug Accupril.
Pfizer, Inc. has won a preliminary injunction halting sales of a generic version of the hypertension drug Accupril, marketed by Israeli generics maker Teva Pharmaceuticals and Indian drug maker Ranbaxy Pharmaceuticals.
Bausch & Lomb has withdrawn its patent infringement lawsuit filed last week against Inverness Medical Innovations Inc., which the eye care maker said was based on erroneous information.
Eye care company Bausch & Lomb Inc. has sued yet another rival over patents for a dietary supplement designed to combat eye disease.
Pfizer Inc. has sued India’s Ranbaxy and Israel’s Teva Pharmaceuticals in New Jersey federal court, alleging that the two companies are infringing a process patent for the hypertension drug Accupril.
Teva Pharmaceutical and GlaxoSmithKline have settled their patent litigation over Glaxo’s Lamictal with a deal under which Teva will be allowed to launch an exclusive generic version later this year.
AT&T has changed the name of its Internet phone service to resolve a trademark infringement dispute with its competitor Vonage, according to Vonage.
Brown Raysman has hired the former head of Coudert Brothers’ intellectual property department for its Los Angeles office.
Northeastern law firm McCarter & English has hired two intellectual property attorneys for its office in Newark, New Jersey from Wolff & Samson PC.
Bolstered by a slew of new pharmaceutical clients, Brown Raysman Millstein Felder & Steiner LLP has seen the revenues from its intellectual property practice nearly double in the past 18 months.
One day after Canadian memory chip maker Mosaid Technologies settled its patent infringement lawsuit against South Korean rival Samsung Electronics, the company said it had filed a similar suit against Korea’s Hynix Semiconductor Inc.
South Korea’s Samsung Electronics has agreed to take a license to settle an increasingly embarrassing patent infringement lawsuit brought by Canadian memory-chip maker Mosaid Technologies.
U.K. drug maker GlaxoSmithKline Plc’s patent lawsuit against Israeli generics maker Teva Pharmaceutical Industries Ltd. over its best-selling anti-epileptic drug Lamictal will be heard in a U.S. court on Tuesday.
A New Jersey company that rebuilds used Fuji Photo Film Co. disposable cameras and sells them without brand names at a discount is infringing Fuji’s patent rights, the U.S. Court of Appeals for the Federal Circuit has affirmed.
A federal district court has ruled that Teva Pharmaceuticals’s generic moexipril infringes a patent held by Schwarz Pharma for the hypertension drug Univasc.
For Gibbons, Del Deo, the key to attracting the right intellectual property attorneys has been a steadfast focus on corporate America.
Former federal intellectual property crime prosecutor Scott S. Christie has joined McCarter & English, LLP, as a partner in the firm’s Newark office.
In a decision that could represent the final blow to an aggressive licensing program by LG Electronics, a federal judge in Northern California has thrown out the Korean electronics maker’s four-year patent lawsuit against U.S. and Taiwanese makers of computers and motherboards.
A U.S. federal judge has denied the appeal of the remaining two sanctions against Samsung Electronics Co. for destroying evidence in a patent dispute with Canadian rival Mosaid Technologies Inc.